Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2023-05-17 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Piano di acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is a press release (COMUNICATO STAMPA) from SVAS BIOSANA dated May 17, 2023. The subject ('Oggetto') is explicitly stated as 'Piano di acquisto azioni proprie' (Share buyback program). The content details the resolution by the Board of Directors to initiate a program for the purchase of its own ordinary shares, including the purpose (liquidity support, employee incentives, extraordinary transactions), duration (18 months), maximum number of shares (20% of share capital), and maximum countervalue (Euro 1,500,000). This directly corresponds to the definition of a company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS).
2023-05-17 Italian
Approvazione Bilancio al 31.12.2022 - Destinazione risultato d'esercizio - Incarico Revisione Legale 2023/2025 - Piano di Acquisto azioni proprie
AGM Information Classification · 98% confidence The document is a press release dated May 16, 2023, originating from Svas Biosana S.p.A. and filed under 'Informazione Regolamentata' (Regulated Information) on Euronext Growth Milan. The subject ('Oggetto') explicitly mentions 'Approvazione Bilancio al 31.12.2022' (Approval of Financial Statements as of 31.12.2022), 'Revisione Legale 2023/2025' (Legal Audit 2023/2025), and 'Piano di Acquisto azioni proprie' (Own Share Purchase Plan). The content details the approval of the 2022 financial statements, including key figures (Revenues, EBITDA, Net Income), the allocation of the profit, the appointment of the auditor (PwC), and authorization for share buybacks. This document is a formal announcement summarizing the key resolutions passed during the Annual General Meeting (Assemblea Ordinaria degli Azionisti). While it contains financial results (which might suggest ER or IR), the primary focus and context are the resolutions passed at the shareholder meeting, specifically the approval of the annual accounts and related corporate actions. The document is a press release summarizing the outcomes of the AGM. Since the core event is the shareholder meeting and its resolutions, and it is not just a simple dividend notice (DIV) or a pure earnings release (ER) which usually precedes the AGM approval, the most fitting category is AGM Information (AGM-R), as it reports on the outcomes of the Annual General Meeting.
2023-05-16 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and explicitly states that the company purchased a specific number of its own shares during the period from May 8 to May 12, 2023, detailing the transaction volume and value. This directly corresponds to the definition of a company reporting transactions in its own shares (share repurchase/issuance). The filing type code for this activity is POS (Transaction in Own Shares). Although it is a press release/communication, the core subject matter is the share repurchase activity itself, making POS more specific than RPA or RNS.
2023-05-12 Italian
Fatturato al 31.03.2023
Earnings Release Classification · 98% confidence The document is a press release (COMUNICATO STAMPA) from Svas Biosana S.p.A. announcing that the Board of Directors examined the consolidated revenue for the first quarter ended March 31, 2023. The key subject is the 'Fatturato al 31.03.2023' (Revenue as of 31.03.2023) and it provides key financial highlights (€ 26.4 million in consolidated revenue, up 24.2% YoY) in a summary format, typical of an initial results announcement, rather than a comprehensive quarterly report (IR) or the full annual report (10-K). This fits the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). Although it mentions the results were 'examined' and provides a table, the format is a brief press release summarizing the period's performance, not the full detailed report. Q1 2023
2023-05-09 Italian
TP ICAP Midcap Annual Conference 2023
Report Publication Announcement Classification · 99% confidence The document is a short press release (4713 characters) announcing the company's participation in the 'TP ICAP Midcap Annual Conference 2023'. It states that the CEO and CFO will present results and strategies to the financial community on May 11, 2023. The text explicitly mentions 'COMUNICATO STAMPA' (Press Release) and directs readers to see the attachment ('Vedi allegato') and the Investor Relations section for the full information. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement stating that information is being presented or published elsewhere, without containing the full report details, should be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this is specifically announcing participation in an investor event where presentations will occur, it functions as an announcement of future investor engagement/presentation material, making RPA the most appropriate fit, as it announces the publication/presentation of company information to investors.
2023-05-09 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is an Italian 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) from Svas Biosana S.p.A. The subject ('Oggetto') is 'Acquisto azioni proprie' (Purchase of own shares). The content details the number of shares repurchased, the average price, and the total consideration over a specific weekly period (May 2nd to May 5th, 2023). This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category (POS). Although it is a regulatory filing (indicated by the 'Informazione Regolamentata' header), the specific nature of the content (share repurchase details) makes 'POS' the most accurate classification over the general 'RNS'.
2023-05-05 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.